ReviewPublished 12 October 2026Metabolic sensing in 3D models of pancreatic ductal adenocarcinoma: probing pH, oxygen, and lactate dynamics to decode chemoresistanceAnna Chiara Siciliano · Stefania Forciniti · Helena Iuele · Federica Carnevali · Giuseppe Gigli · Loretta L. del MercatoFrontiers in Bioengineering and Biotechnologydoi 10.3389/fbioe.2026.1926254
ReviewPublished 12 October 2026Progress in research on gut microbiota regulation of tumorigenesis, progression, and therapeutic response via inflammatory cytokinesYan Liu · Dan Zang · Jun ChenFrontiers in Immunologydoi 10.3389/fimmu.2026.1922678
ReviewPublished 9 October 2026From image biomarkers to treatment decisions: multimodal AI and clinical translation in gynecologic oncologyMohamad Bakir · Mohammad Khaldoun Al Masri · Yousef Mushtaha · Narmeen Shaikh · Mohammed Raddaoui · Khalid Said MohammadFrontiers in Oncologydoi 10.3389/fonc.2026.1960963
CorrectionPublished 9 October 2026Correction: Real world genomic profiling in non-small cell lung cancer reveals regional variations with clinical implicationsFrontiers Production OfficeFrontiers in Oncologydoi 10.3389/fonc.2026.2013767
Mini ReviewPublished 8 October 2026Metabolic rewiring at the obesity–estrogen–polyamine axis in endometrial cancer: emerging mechanisms and translational opportunitiesDaniel Simancas-Racines · Dolores Jima Gavilanes · Andri Matos · Gabriele Davide Bigoni-Ordóñez · Claudia Reytor-GonzálezFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1954981
EditorialPublished 30 September 2026Editorial: Cancer biomarkers: molecular insights into diagnosis, prognosis, and risk prediction: volume IIMatteo Becatti · Giuseppe Bronte · Shaoquan ZhengFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1999668
ReviewPublished 30 September 2026Gut microbiota–cancer crosstalk: emerging molecular targets for personalized cancer treatment- a comprehensive reviewPooja Negi · Arpita Upreti · Preeti Budhlakoti · Amit Kumar Sen · Mitali Danu · Sumit Tewari · Nirmal Joshi · Deepak Chandra JoshiFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1924197
PerspectivePublished 23 September 2026Multimodal endoscopic diagnosis in biliary oncology: integrating EUS-guided tissue acquisition and cholangioscopy for personalized cancer carePetko Karagyozov · Nadica Male · Kalina Panova · Stela NikolovaFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1924535
ReviewPublished 22 September 2026The impact of deep learning and omics data in transforming precision therapy for brain cancerSana Munquad · Anam Upadhyay · Asim Bikas DasFrontiers in Bioinformaticsdoi 10.3389/fbinf.2026.1811813
ReviewPublished 22 September 2026GPCR signaling systems facilitate precision interventions for multi-oncology therapyAshley Del Pozo · Mia Pardo · Tabitha Boeringer · Carter J. Craig · Ramzia Sorathia · Madeline Millican · Stuart MaudsleyFrontiers in Systems Biologydoi 10.3389/fsysb.2026.1940022
ReviewPublished 17 September 2026Carbon dots in cancer therapy: a novel approach to targeted drug delivery and reduced toxicity in gallbladder cancerMahvish Fatima · Warda Parveen · Norah M. Almaneai · Attalla F. El-kott · Mohammed A. AlShehri · Waleed Eltantawy · Nosheen Kanwal · Zaheera SaadiaFrontiers in Chemistrydoi 10.3389/fchem.2026.1899601
ReviewPublished 8 September 2026Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncologyEmmanuel Ifeanyi ObeaguOncology Reviewsdoi 10.3389/or.2026.1909404
Original ResearchPublished 4 August 2026A machine learning framework for predictive interpretation of variants of uncertain significance in hereditary cancerNayeema Nizamuddin · Soham Biswas · Akshaykumar Zawar · Poonam Deshpande · Layal Yasin · Prashanth N. SuravajhalaFrontiers in Systems Biologydoi 10.3389/fsysb.2026.1828263
ReviewPublished 16 July 2026Decoding drug resistance and apoptosis in biliary tract cancers using 3D tumor modelsGurpreet Singh Gill · Om Saswat Sahoo · Arnab Nayek · Sajib Kumar Sarkar · Kailash Chand Kurdia · Nidhi Bhardwaj · Chandan J. Das · Saurabh Galodha · Gitanjali Goyal · Subhradip Karmakar · Ruby DharFrontiers in Cell Deathdoi 10.3389/fceld.2026.1819303
ReviewPublished 14 July 2026Beyond static biomarkers: systems biology and AI for decoding cancer dynamicsSubhajit Dutta · Anjana GoliFrontiers in Systems Biologydoi 10.3389/fsysb.2026.1855016
ReviewPublished 22 June 2026Bidirectional regulatory mechanisms and therapeutic prospects of tumor hypercoagulable state and immunosuppressive tumor microenvironmentYongli Lai · Ruyu Qin · Zhaidong LiuOncology Reviewsdoi 10.3389/or.2026.1863533
ReviewPublished 15 June 2026Artificial intelligence–driven multimodal fusion for precision diagnosis and personalized management of breast cancerMingyu Zhang · Juhang Chu · Zixin Wang · Yaru Wang · Luyao Huang · Mingping QianOncology Reviewsdoi 10.3389/or.2026.1849152
ReviewPublished 29 May 2026ECM-targeted cancer interventions: nanobiotechnological paradigms for imaging and therapyTrinayan Deka · Nayan Moni Choudhury · Nilay KapinjalFrontiers in Nanotechnologydoi 10.3389/fnano.2026.1742127
Mini ReviewPublished 13 May 2026Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomasJulia A. Yescas · Christopher G. Bunick · Ayman Grada · Joan Guitart · Carlos A. Torres-Cabala · I. Caroline Le Poole · Xiaolong A. ZhouFrontiers in Hematologydoi 10.3389/frhem.2026.1812908
Mini ReviewPublished 10 April 2026Epi-liquidomics: redefining cancer diagnostics through epigenetic profilingShahper Nazeer Khan · Mohammad Harris Siddiqui · Aamir Ahmad · Luca Guarnera · Salamatu Tijjani IsahFrontiers in Epigenetics and Epigenomicsdoi 10.3389/freae.2026.1813822
Mini ReviewPublished 20 March 2026Beyond mutations: personalising oncology via RNA-editingIvo Fierro-MontiFrontiers in RNA Researchdoi 10.3389/frnar.2026.1779364
Original ResearchPublished 13 November 2025Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancerAlp Inci · Isabell Witzel · Holger Moch · Sepehr Rahmani-Khajouei · Martin Zoche · Eleftherios Pierre SamartzisPathology and Oncology Researchdoi 10.3389/pore.2025.1612266
